Clinical trials
Completed Muscular Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| Institut de Myologie, France | 2 |
| University of Erlangen-Nürnberg Medical School | 2 |
| Vanderbilt University | 2 |
| Alexandria University | 1 |
| BTL Industries Ltd. | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Cairo University | 1 |
| Centre d'Investigation Clinique et Technologique 805 | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Diseases | 40 |
| Myositis | 4 |
| Neuromuscular Diseases | 4 |
| Muscle Weakness | 3 |
| Muscular Dystrophies | 3 |
| Musculoskeletal Diseases | 3 |
| Rheumatic Diseases | 3 |
| Asthenia | 2 |
| Brain Injuries | 2 |
| Dementia | 2 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.